Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Arch Pharm (Weinheim) ; 355(2): e2100338, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34661935

RESUMEN

Neglected tropical diseases are a diverse group of communicable diseases that are endemic in low- or low-to-middle-income countries located in tropical and subtropical zones. The number and availability of drugs for treating these diseases are low, the administration route is inconvenient in some cases, and most of them have safety, efficacy, or adverse/toxic reaction issues. The need for developing new drugs to deal with these issues is clear, but one of the most drastic consequences of this negligence is the lack of interest in the research and development of new therapeutic options among major pharmaceutical companies. Positive changes have been achieved over the last few years, although the overall situation remains alarming. After more than one decade since the original work reviewing antiprotozoal agents came to light, now it is time to question ourselves: How has the scenario for the treatment of protozoal diseases such as malaria, leishmaniasis, human African trypanosomiasis, and American trypanosomiasis changed? This review covers the last decade in terms of the drugs currently available for the treatment of these diseases as well as the clinical candidates being currently investigated.


Asunto(s)
Antiprotozoarios/farmacología , Enfermedades Desatendidas/tratamiento farmacológico , Infecciones por Protozoos/tratamiento farmacológico , Animales , Desarrollo de Medicamentos/tendencias , Humanos , Enfermedades Desatendidas/parasitología , Infecciones por Protozoos/parasitología
2.
Bioorg Med Chem ; 24(18): 4492-4498, 2016 09 15.
Artículo en Inglés | MEDLINE | ID: mdl-27485600

RESUMEN

Ten 1-phenyl-1H-pyrazolo[3,4-b]pyridine derivatives connected by a linker group to benzenesulfonamide moieties with different substituents in the 4-position were synthesized and assayed against Plasmodium falciparum. These ten compounds exhibited activity in vitro against the chloroquine-resistant clone W2 with IC50 values ranging from 3.46 to 9.30µM. The most active derivatives with substituent R2=Cl or CH3 at the benzenesulfonamide moiety exhibited the lowest IC50. Compounds with an R1=CO2Et substituent at the 5-position of the 1H-pyrazolo[3,4-b]pyridine ring presented lower activity than those with a CN substituent. The 1H-pyrazolo[3,4-b]pyridine system appears to be promising for further studies as an antimalarial for overcoming the burden of resistance in P. falciparum.


Asunto(s)
Antimaláricos/síntesis química , Antimaláricos/farmacología , Plasmodium falciparum/efectos de los fármacos , Pirazoles/farmacología , Piridinas/farmacología , Sulfonamidas/farmacología , Animales , Antimaláricos/química , Diseño de Fármacos , Concentración 50 Inhibidora , Pirazoles/química , Piridinas/química , Análisis Espectral/métodos , Sulfonamidas/química
3.
Curr Org Synth ; 16(6): 855-899, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31984910

RESUMEN

Multicomponent reactions (MCRs) are composed of three or more reagents in which the final product has all or most of the carbon atoms from its starting materials. These reactions represent, in the medicinal chemistry context, great potential in the research for new bioactive compounds, since their products can present great structural complexity. The aim of this review is to present the main multicomponent reactions since the original report by Strecker in 1850 from nowadays, covering their evolution, highlighting their significance in the discovery of new bioactive compounds. The use of MCRs is, indeed, a growing field of interest in the synthesis of bioactive compounds and approved drugs, with several examples of commerciallyavailable drugs that are (or can be) obtained through these protocols.


Asunto(s)
Compuestos Orgánicos/síntesis química , Técnicas de Química Sintética/métodos , Indicadores y Reactivos/química , Estereoisomerismo
4.
PLoS One ; 11(8): e0160842, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27508497

RESUMEN

Microtubules play critical roles in vital cell processes, including cell growth, division, and migration. Microtubule-targeting small molecules are chemotherapeutic agents that are widely used in the treatment of cancer. Many of these compounds are structurally complex natural products (e.g., paclitaxel, vinblastine, and vincristine) with multiple stereogenic centers. Because of the scarcity of their natural sources and the difficulty of their partial or total synthesis, as well as problems related to their bioavailability, toxicity, and resistance, there is an urgent need for novel microtubule binding agents that are effective for treating cancer but do not have these disadvantages. In the present work, our lead discovery effort toward less structurally complex synthetic compounds led to the discovery of a series of acridinones inspired by the structure of podophyllotoxin, a natural product with important microtubule assembly inhibitory activity, as novel mechanism-based tubulin assembly inhibitors with potent anticancer properties and low toxicity. The compounds were evaluated in vitro by wound healing assays employing the metastatic and triple negative breast cancer cell line MDA-MB-231. Four compounds with IC50 values between 0.294 and 1.7 µM were identified. These compounds showed selective cytotoxicity against MDA-MB-231 and DU-145 cancer cell lines and promoted cell cycle arrest in G2/M phase and apoptosis. Consistent with molecular modeling results, the acridinones inhibited tubulin assembly in in vitro polymerization assays with IC50 values between 0.9 and 13 µM. Their binding to the colchicine-binding site of tubulin was confirmed through competitive assays.


Asunto(s)
Antineoplásicos/química , Antineoplásicos/farmacología , Moduladores de Tubulina/farmacología , Acridinas/química , Apoptosis/efectos de los fármacos , Sitios de Unión , Unión Competitiva , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Colchicina/metabolismo , Diseño de Fármacos , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Modelos Moleculares , Estructura Molecular , Podofilotoxina/química , Tubulina (Proteína)/metabolismo , Moduladores de Tubulina/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA